Validation of a Cytological Classification System for the Rapid On-Site Evaluation (Rose) of Pulmonary and Mediastinal Needle Aspirates

Rapid on-site evaluation (ROSE) is a procedure that allows immediate assessment of adequacy of cytological specimens obtained by fine needle aspiration (FNA). The application of ROSE diagnostic categories has been applied in various organs, but not in thoracic pathology. We aimed to retrospectively...

Full description

Bibliographic Details
Main Authors: Lina Zuccatosta, Giulio Rossi, Stefano Gasparini, Maurizio Ferretti, Federico Mei, Michele Sediari, Francesca Barbisan, Gaia Goteri, Giuseppe Maria Corbo, Alessandro Di Marco Berardino
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/11/2777
_version_ 1797465590403694592
author Lina Zuccatosta
Giulio Rossi
Stefano Gasparini
Maurizio Ferretti
Federico Mei
Michele Sediari
Francesca Barbisan
Gaia Goteri
Giuseppe Maria Corbo
Alessandro Di Marco Berardino
author_facet Lina Zuccatosta
Giulio Rossi
Stefano Gasparini
Maurizio Ferretti
Federico Mei
Michele Sediari
Francesca Barbisan
Gaia Goteri
Giuseppe Maria Corbo
Alessandro Di Marco Berardino
author_sort Lina Zuccatosta
collection DOAJ
description Rapid on-site evaluation (ROSE) is a procedure that allows immediate assessment of adequacy of cytological specimens obtained by fine needle aspiration (FNA). The application of ROSE diagnostic categories has been applied in various organs, but not in thoracic pathology. We aimed to retrospectively assess the concordance with the final diagnosis of a categorization from C1 (inadequate) to C5 (neoplastic) during ROSE performed with bronchoscopic or percutaneous sampling procedures of thoracic lesions in a large series of consecutive cases. This retrospective single-center study evaluated 2282 consecutive ROSEs performed on 1827 patients from January 2016 to December 2020 in 994 cases of transbronchial needle aspiration (TBNA) in peripheral pulmonary lesions, in 898 transthoracic FNAs, in 318 ultrasound-guided TBNAs, in 50 conventional TBNAs and in 22 endobronchial TBNAs. False positive and false negative cases of ROSE were 43 (1.88%) and 73 (3.2%), respectively, when compared with the definitive diagnosis. The sensitivity, specificity and the positive and negative prognostic values of ROSE were 94.84%, 95.05%, 96.89% and 91.87%, respectively. Overall concordance between ROSE and the final diagnosis was 0.8960 (Cohen’s kappa). No significant differences were observed in terms of sampling procedures and type and location of the lesions. A tiered classification scheme of ROSE from C1 to C5 during bronchoscopic and percutaneous sampling procedures is helpful in effectively guiding clinical management of patients with thoracic lesions.
first_indexed 2024-03-09T18:23:40Z
format Article
id doaj.art-ab6c3ace2c7743288a9e0da84d9bf175
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-09T18:23:40Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-ab6c3ace2c7743288a9e0da84d9bf1752023-11-24T08:04:08ZengMDPI AGDiagnostics2075-44182022-11-011211277710.3390/diagnostics12112777Validation of a Cytological Classification System for the Rapid On-Site Evaluation (Rose) of Pulmonary and Mediastinal Needle AspiratesLina Zuccatosta0Giulio Rossi1Stefano Gasparini2Maurizio Ferretti3Federico Mei4Michele Sediari5Francesca Barbisan6Gaia Goteri7Giuseppe Maria Corbo8Alessandro Di Marco Berardino9Pulmonary Diseases Unit, Azienda “Ospedali Riuniti”, 60126 Ancona, ItalyPathology Unit, Fondazione Poliambulanza Hospital Institute, 25124 Brescia, ItalyPulmonary Diseases Unit, Azienda “Ospedali Riuniti”, 60126 Ancona, ItalyPathological Anatomy Institute, Polytechnic University of Marche Region, 60126 Ancona, ItalyPulmonary Diseases Unit, Azienda “Ospedali Riuniti”, 60126 Ancona, ItalyPulmonary Diseases Unit, Azienda “Ospedali Riuniti”, 60126 Ancona, ItalyPathological Anatomy Institute, Polytechnic University of Marche Region, 60126 Ancona, ItalyPathological Anatomy Institute, Polytechnic University of Marche Region, 60126 Ancona, ItalyIRCCS, Fondazione Policlinico Universitario A. Gemelli, 00168 Roma, ItalyPulmonary Diseases Unit, Azienda “Ospedali Riuniti”, 60126 Ancona, ItalyRapid on-site evaluation (ROSE) is a procedure that allows immediate assessment of adequacy of cytological specimens obtained by fine needle aspiration (FNA). The application of ROSE diagnostic categories has been applied in various organs, but not in thoracic pathology. We aimed to retrospectively assess the concordance with the final diagnosis of a categorization from C1 (inadequate) to C5 (neoplastic) during ROSE performed with bronchoscopic or percutaneous sampling procedures of thoracic lesions in a large series of consecutive cases. This retrospective single-center study evaluated 2282 consecutive ROSEs performed on 1827 patients from January 2016 to December 2020 in 994 cases of transbronchial needle aspiration (TBNA) in peripheral pulmonary lesions, in 898 transthoracic FNAs, in 318 ultrasound-guided TBNAs, in 50 conventional TBNAs and in 22 endobronchial TBNAs. False positive and false negative cases of ROSE were 43 (1.88%) and 73 (3.2%), respectively, when compared with the definitive diagnosis. The sensitivity, specificity and the positive and negative prognostic values of ROSE were 94.84%, 95.05%, 96.89% and 91.87%, respectively. Overall concordance between ROSE and the final diagnosis was 0.8960 (Cohen’s kappa). No significant differences were observed in terms of sampling procedures and type and location of the lesions. A tiered classification scheme of ROSE from C1 to C5 during bronchoscopic and percutaneous sampling procedures is helpful in effectively guiding clinical management of patients with thoracic lesions.https://www.mdpi.com/2075-4418/12/11/2777ROSEbronchoscopytransthoracic needle aspirationEBUS-TBNAcytology
spellingShingle Lina Zuccatosta
Giulio Rossi
Stefano Gasparini
Maurizio Ferretti
Federico Mei
Michele Sediari
Francesca Barbisan
Gaia Goteri
Giuseppe Maria Corbo
Alessandro Di Marco Berardino
Validation of a Cytological Classification System for the Rapid On-Site Evaluation (Rose) of Pulmonary and Mediastinal Needle Aspirates
Diagnostics
ROSE
bronchoscopy
transthoracic needle aspiration
EBUS-TBNA
cytology
title Validation of a Cytological Classification System for the Rapid On-Site Evaluation (Rose) of Pulmonary and Mediastinal Needle Aspirates
title_full Validation of a Cytological Classification System for the Rapid On-Site Evaluation (Rose) of Pulmonary and Mediastinal Needle Aspirates
title_fullStr Validation of a Cytological Classification System for the Rapid On-Site Evaluation (Rose) of Pulmonary and Mediastinal Needle Aspirates
title_full_unstemmed Validation of a Cytological Classification System for the Rapid On-Site Evaluation (Rose) of Pulmonary and Mediastinal Needle Aspirates
title_short Validation of a Cytological Classification System for the Rapid On-Site Evaluation (Rose) of Pulmonary and Mediastinal Needle Aspirates
title_sort validation of a cytological classification system for the rapid on site evaluation rose of pulmonary and mediastinal needle aspirates
topic ROSE
bronchoscopy
transthoracic needle aspiration
EBUS-TBNA
cytology
url https://www.mdpi.com/2075-4418/12/11/2777
work_keys_str_mv AT linazuccatosta validationofacytologicalclassificationsystemfortherapidonsiteevaluationroseofpulmonaryandmediastinalneedleaspirates
AT giuliorossi validationofacytologicalclassificationsystemfortherapidonsiteevaluationroseofpulmonaryandmediastinalneedleaspirates
AT stefanogasparini validationofacytologicalclassificationsystemfortherapidonsiteevaluationroseofpulmonaryandmediastinalneedleaspirates
AT maurizioferretti validationofacytologicalclassificationsystemfortherapidonsiteevaluationroseofpulmonaryandmediastinalneedleaspirates
AT federicomei validationofacytologicalclassificationsystemfortherapidonsiteevaluationroseofpulmonaryandmediastinalneedleaspirates
AT michelesediari validationofacytologicalclassificationsystemfortherapidonsiteevaluationroseofpulmonaryandmediastinalneedleaspirates
AT francescabarbisan validationofacytologicalclassificationsystemfortherapidonsiteevaluationroseofpulmonaryandmediastinalneedleaspirates
AT gaiagoteri validationofacytologicalclassificationsystemfortherapidonsiteevaluationroseofpulmonaryandmediastinalneedleaspirates
AT giuseppemariacorbo validationofacytologicalclassificationsystemfortherapidonsiteevaluationroseofpulmonaryandmediastinalneedleaspirates
AT alessandrodimarcoberardino validationofacytologicalclassificationsystemfortherapidonsiteevaluationroseofpulmonaryandmediastinalneedleaspirates